Continuous glucose monitoring

Current Opinion in Endocrinology and Diabetes

Volumn 12, Issue 4, 2005, Pages 273-279

  Buckingham, Bruce ^a   Block, Jen ^a   Wilson, Darrell M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Continuous glucose monitoring system; Glucose sensors; GlucoWatch; Navigator

Indexed keywords

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPOGLYCEMIA; REVIEW; SENSOR;

EID: 24044474716     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46:271-286.
2. Bounder J, Hagstrom-Toft E, Ungerstedt U, et al. Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997; 20:64-70.
3. Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000; 2:49-56.
4. Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000; 2:S19-S26.
5. Klonoff DC. The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care 2004; 27:834-836.
6. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003; 5:781-789.
7. The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 2003; 5:791-800.
8. Accuracy of the Modified Continuous Glucose Monitoring (CGMS®) sensor in an outpatient setting: results from a Diabetes Research in Children Network (DirecNet) study. Diabetes Technol Ther 2005; 7:109-114.
9. Mauras N, Beck RW, Ruedy KJ, et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr 2004; 144:770-775.
10. Tsalikian E, Kollman C, Mauras N, et al. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther 2004; 6: 559-566.
11. Kovatchev BP, Gonder-Frederick LA, Cox DJ, et al. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004; 27:1922-1928. An important paper for putting forth a method for evaluating the clinical implications of decisions made using data from a real-time continuous glucose sensor.
12. Rebrin K, Steil GM, van Antwerp WP, et al. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999; 277:E561-E571.
13. Steil GM, Rebrin K, Mastrototaro J, et al. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther 2003; 5:27-31.
14. Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24:1858-1862.
15. Tanenberg R, Bode B, Lane W, et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004; 79:1521-1526. One of the first major, randomized clinical trials to look at benefit from using CGMS.
16. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111:933-938.
17. Jeha GS, Karaviti LP, Anderson B, et al. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 2004; 27:2881-2886. This study again demonstrates the frequent hyperglycemia and hypoglycemia missed with conventional blood glucose monitoring.
18. Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001; 24:2030-2034.
19. Chico A, Vidal-Rios P, Subira M, et al. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26:1153-1157.
20. Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001; 107:222-226.
21. Buckingham B, Block J, Burdick J, et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther 2005; 7:440-447.
22. Chase HP, Beck R, Tamborlane W, et al. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28:1101-1106.
23. Nunnold T, Colberg SR, Herriott MT, et al. Use of the noninvasive GlucoWatch Biographer during exercise of varying intensity. Diabetes Technol Ther 2004; 6:454-462.
24. Bode B, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 2004; 6:105-113. First paper describing clinical use of the Guardian monitor with real-time alarms.
25. Feldman B, Brazg R, Schwartz S, et al. A continuous glucose sensor based on wired enzyme technology-results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003; 5:769-779.
26. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004; 27:734-738. First clinical outcomes paper describing use of a continuous, implantable subcutaneous glucose sensor.
27. Rebrin K, Steil G, Panteleon AE, et al. Closed-loop subcutaneous insulin delivery based on subcutaneous glucose sensing in adults. Diabetologia 2004; 47:A93.
28. Conrad SC, Mastrototaro JJ, Gitelman SE. The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatr Endocrinol Metab 2004; 17:281-288.
29. Hershkovitz E, Rachmel A, Ben-Zaken H, et al. Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 2001; 24:863-869.
30. Kerssen A, de Valk HW, Visser GH. The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technol Ther 2004; 6:645-651.
31. Dobson L, Sheldon CD, Hattersley AT. Conventional measures under-estimate glycaemia in cystic fibrosis patients. Diabet Med 2004; 21:691-696.
32. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
33. Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004; 6:339-347. No significant problems with using the CGMS in the intensive care unit setting.
34. Wang X. Application of the Continuous Glucose Monitoring System (CGMS) in the 72-hour fast test in two patients with hypoglycemia. Diabetes Technol Ther 2004; 6:883-886.
35. Amin R, Ross K, Acerini CL, et al. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003; 26:662-667.
36. Kaufman FR, Austin J, Neinstein A, et al. Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes. J Pediatr 2002; 141:625-630.